Lynx Investment Advisory’s Ingevity NGVT Stock Holding History

Lynx Investment Advisory’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14	Closed	-$612	–	543
2024 Q2	$612	Buy	+14	New	+$677	﹤0.01%	716

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Lynx Investment Advisory's NGVT Position: Q3 2024 in Review

Lynx Investment Advisory sold out of Ingevity (NGVT) in Q3 2024, closing a stake of 14 shares — an estimated $612 sold.

Lynx Investment Advisory first reported a position in NGVT in Q2 2024 and held it in 1 quarter. The position peaked at $612 in Q2 2024. 261 funds tracked by Wall St. Rank hold NGVT as of Q3 2024.

Lynx Investment Advisory reported no remaining Ingevity position as of Q3 2024 after selling out during the quarter.
Lynx Investment Advisory sold 14 Ingevity shares in Q3 2024, an estimated $612.
Lynx Investment Advisory first reported a position in Ingevity in Q2 2024 and held it in 1 quarter.
Lynx Investment Advisory's Ingevity position peaked at $612 in Q2 2024.
261 funds tracked by Wall St. Rank held Ingevity as of Q3 2024.

Based on Lynx Investment Advisory's 13F filing for Q3 2024, filed 4 Nov 2024.